Embracing an integromic approach to tissue biomarker research in cancer: Perspectives and lessons learned

Briefings in Bioinformatics

Volumn 18, Issue 4, 2017, Pages 634-646

  Li, Gerald ^a   Bankhead, Peter ^a   Dunne, Philip D ^a   O'Reilly, Paul G ^a   James, Jacqueline A ^a   Salto Tellez, Manuel ^a   Hamilton, Peter W ^a   McArt, Darragh G ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Big data; Biomarkers; Digital pathology; Integromics; Interdisciplinary teamwork; Omics

Indexed keywords

TUMOR MARKER;

BIOLOGY; HUMAN; MEDICAL RESEARCH; NEOPLASM; PERSONALIZED MEDICINE;

BIOMARKERS, TUMOR; BIOMEDICAL RESEARCH; COMPUTATIONAL BIOLOGY; HUMANS; NEOPLASMS; PRECISION MEDICINE;

EID: 85027161613     PISSN: 14675463     EISSN: 14774054     Source Type: Journal    
DOI: 10.1093/bib/bbw044     Document Type: Article

References (100)

1. Canuel V, Rance B, Avillach P, et al. Translational research platforms integrating clinical and omics data: a review of publicly available solutions. Brief Bioinform 2015;16:280-90
2. Noor AM, Holmberg L, Gillett C, et al. Big Data: the challenge for small research groups in the era of cancer genomics. Br J Cancer 2015;113:1405-12
3. PathXL Xplore. http://www. pathxl. com/pathxl-research/pathxl-xplore (20 November 2015, date last accessed)
4. Biomarker Interpretation Workflow-OncoMark. http://www. oncomark. com/go/products/biomarker-interpretation-work flow (23 November 2015, date last accessed)
5. Denaxas SC, George J, Herrett E, et al. Data resource profile: cardiovascular disease research using linked bespoke studies and electronic health records (CALIBER). Int J Epidemiol 2012;41:1625-38
6. Lubbock ALR, Katz E, Harrison DJ, et al. TMA Navigator: network inference, patient stratification and survival analysis with tissue microarray data. Nucleic Acids Res 2013;41: W562-8
7. Giardine B, Riemer C, Hardison RC, et al. Galaxy: a platform for interactive large-scale genome analysis. Genome Res 2005;15: 1451-5
8. Goecks J, Nekrutenko A, Taylor J. Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences. Genome Biol 2010;11:R86
9. Madhavan S, Gusev Y, Harris M, et al. G-DOC: a systems medicine platform for personalized oncology. Neoplasia 2011;13: 771-83
10. Dander A, Baldauf M, Sperk M, et al. Personalized Oncology Suite: integrating next-generation sequencing data and whole-slide bioimages. BMC Bioinformatics 2014;15:306
11. Kartashov AV, Barski A. BioWardrobe: an integrated platform for analysis of epigenomics and transcriptomics data. Genome Biol 2015;16:158
12. Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42:377-81
13. Szalma S, Koka V, Khasanova T, et al. Effective knowledge management in translational medicine. J Transl Med 2010;8:1-9
14. Manley S, Mucci NR, De Marzo AM, et al. Relational database structure to manage high-density tissue microarray data and images for pathology studies focusing on clinical outcome: the prostate specialized program of research excellence model. Am J Pathol 2001;159:837-43
15. Weinstein JN. Integromic analysis of the NCI-60 cancer cell lines. Breast Dis 2004;19:11-22
16. Weinstein JN, Pommier Y. Transcriptomic analysis of the NCI-60 cancer cell lines. C R Biol 2003;326:909-20
17. Yu P, Artz D, Warner J. Electronic health records (EHRs): supporting ASCO's vision of cancer care. Am Soc Clin Oncol Educ Book 2014;225-31
18. McArt DG, Blayney JK, Boyle DP, et al. PICan: an integromics framework for dynamic cancer biomarker discovery. Mol Oncol 2015;9:1234-40
19. Hudson TJ Anderson W. The International Cancer Genome Consortium, et al. International network of cancer genome projects. Nature 2010;464:993-8
20. Home j Global Alliance for Genomics and Health. https://genomicsandhealth. org/(15 March 2016, date last accessed)
21. The 1000 Genomes Project Consortium. A global reference for human genetic variation. Nature 2015;526:68-74
22. Collins FS, Varmus H. A New Initiative on Precision Medicine. N Engl J Med 2015;372:793-5
23. Kolesnikov N, Hastings E, Keays M, et al. ArrayExpress update-simplifying data submissions. Nucleic Acids Res 2015;43: D1113-6
24. Leinonen R, Akhtar R, Birney E, et al. The European Nucleotide Archive. Nucleic Acids Res 2011;39:D28-31
25. The Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008;455: 1061-8
26. Home-The Cancer Genome Atlas-Cancer Genome-TCGA. http://cancergenome. nih. gov/(1 December 2015, date last accessed)
27. Kristensen VN, Lingjærde OC, Russnes HG, et al. Principles and methods of integrative genomic analyses in cancer. Nat Rev Cancer 2014;14:299-313
28. Guinney J, Dienstmann R, Wang X, et al. The consensus molecular subtypes of colorectal cancer. Nat Med 2015;21: 1350-6
29. Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 2013;6:pl1
30. Cerami E, Gao J, Dogrusoz U, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2012;2:401-4
31. Forbes SA, Beare D, Gunasekaran P, et al. COSMIC: exploring the world's knowledge of somatic mutations in human cancer. Nucleic Acids Res 2015;43:D805-11
32. Broad GDAC Firehose. http://gdac. broadinstitute. org/(22 March 2016, date last accessed)
33. Le Cao K-A, González I, Déjean S. integrOmics: an R package to unravel relationships between two omics datasets. Bioinformatics 2009;25:2855-6
34. Waller T, Gubala T, Sarapata K, et al. DNA microarray integromics analysis platform. BioData Min 2015;8:18
35. Cecic IK, Li G, MacAulay C. Technologies supporting analytical cytology: clinical, research and drug discovery applications. J Biophotonics 2012;5:313-26
36. Rocha R, Vassallo J, Soares F, et al. Digital slides: present status of a tool for consultation, teaching, and quality control in pathology. Pathol Res Pract 2009;205:735-41
37. Pantanowitz L, Valenstein P, Evans A, et al. Review of the current state of whole slide imaging in pathology. J Pathol Inform 2011;2:36
38. Brachtel E, Yagi Y. Digital imaging in pathology-current applications and challenges. J Biophotonics 2012;5:327-35
39. Hamilton PW, Bankhead P, Wang Y, et al. Digital pathology and image analysis in tissue biomarker research. Methods 2014;70:59-73
40. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods 2012;9:671-5
41. Schindelin J, Arganda-Carreras I, Frise E, et al. Fiji-an Open Source platform for biological image analysis. Nat Methods 2012;9:676-82. 10. 1038/nmeth. 2019
42. de Chaumont F, Dallongeville S, Chenouard N, et al. Icy: an open bioimage informatics platform for extended reproducible research. Nat Methods 2012;9:690-6
43. Sommer C, Straehle C, Kothe U, et al. Ilastik: interactive learning and segmentation toolkit. In: Biomedical Imaging: from Nano to Macro, 2011 IEEE International Symposium on, 2011. pp. 230-233. IEEE
44. Hamilton PW, van Diest PJ, Williams R, et al. Do we see what we think we see? The complexities of morphological assessment. J Pathol 2009;218:285-91
45. Salto-Tellez M, James JA, Hamilton PW. Molecular pathology-the value of an integrative approach. Mol Oncol 2014;8:1163-8
46. Li G, van Niekerk D, Miller D, et al. Molecular fixative enables expression microarray analysis of microdissected clinical cervical specimens. Exp Mol Pathol 2014;96:168-77
47. Galon J, Mlecnik B, Bindea G, et al. Towards the introduction of the 'Immunoscore' in the classification of malignant tumours. J Pathol 2014;232:199-209
48. R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing, 2015
49. Baier T, Neuwirth E. Excel: COM. R Comput Stat 2007;22:91-108
50. McCarty KS, Miller LS, Cox EB, et al. Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med 1985;109:716-21
51. Goulding H, Pinder S, Cannon P, et al. A new immunohistochemical antibody for the assessment of estrogen receptor status on routine formalin-fixed tissue samples. Hum Pathol 1995;26:291-4
52. Leek JT, Scharpf RB, Bravo HC, et al. Tackling the widespread and critical impact of batch effects in high-throughput data. Nat Rev Genet 2010;11:733-9
53. Lauss M, Visne I, Kriegner A, et al. Monitoring of Technical Variation in Quantitative High-Throughput Datasets. Cancer Inform 2013;12:193-201
54. Codd EF. Normalized Data Base Structure: a Brief Tutorial. In: Proceedings of the 1971 ACM SIGFIDET (Now SIGMOD) Workshop on Data Description, Access and Control, San Diego, CA, USA, 1971. pp. 1-17. Association for Computing Machinery, New York, NY
55. Kacprzyk J, Zadrozny S, De Tré G. Fuzziness in database management systems: half a century of developments and future prospects. Fuzzy Sets Syst 2015;281:300-7
56. Bosc P, Pivert O, Farquhar K. Integrating fuzzy queries into an existing database management system: an example. Int J Intell Syst 1994;9:475-92
57. Duggal R, Khatri SK, Shukla B. Improving patient matching: single patient view for Clinical Decision Support using Big Data analytics. In: 2015 4th International Conference on Reliability, Infocom Technologies and Optimization (ICRITO) (Trends and Future Directions), Noida, India, 2015, pp. 1-6. IEEE, New York, NY
58. OpenSeadragon. https://openseadragon. github. io/(7 April 2016, date last accessed)
59. Allred DC, Bustamante MA, Daniel CO, et al. Immunocytochemical analysis of estrogen receptors in human breast carcinomas: evaluation of 130 cases and review of the literature regarding concordance with biochemical assay and clinical relevance. Arch Surg 1990;125:107-13
60. Singh R, Chubb L, Pantanowitz L, et al. Standardization in digital pathology: supplement 145 of the DICOM standards. J Pathol Inform 2011;2:23
61. Linkert M, Rueden CT, Allan C, et al. Metadata matters: access to image data in the real world. J Cell Biol 2010;189:777-82
62. The HDF Group. HDF Group-HDF5. https://www. hdfgroup. org/HDF5/(3 January 2016, date last accessed)
63. Sommer C, Held M, Fischer B, et al. CellH5: a format for data exchange in high-content screening. Bioinformatics 2013;29: 1580-2
64. Allan C, Burel J-M, Moore J, et al. OMERO: flexible, modeldriven data management for experimental biology. Nat Methods 2012;9:245-53
65. Marée R, Rollus L, Stévens B, et al. Collaborative analysis of multi-gigapixel imaging data using Cytomine. Bioinformatics 2016;32:1395-1401
66. DigitalScope V5. http://www. digitalscope. org/(26 November 2015, date last accessed)
67. Astier Y, Braha O, Bayley H. Toward single molecule DNA sequencing: direct identification of ribonucleoside and deoxyribonucleoside 5'-monophosphates by using an engineered protein nanopore equipped with a molecular adapter. J Am Chem Soc 2006;128:1705-10
68. Stoddart D, Heron AJ, Mikhailova E, et al. Single-nucleotide discrimination in immobilized DNA oligonucleotides with a biological nanopore. Proc Natl Acad Sci USA 2009;106:7702-7
69. Flusberg BA, Webster D, Lee J, et al. Direct detection of DNA methylation during single-molecule, real-time sequencing. Nat Methods 2010;7:461-5
70. Roberts RJ, Carneiro MO, Schatz MC. The advantages of SMRT sequencing. Genome Biol 2013;14:405
71. Sheth AP, Larson JA. Federated database systems for managing distributed, heterogeneous, and autonomous databases. ACM Comput Surv 1990;22:183-236
72. Baker EJ. Biological databases for behavioral neurobiology. Int Rev Neurobiol 2012;103:19-38
73. Pääkkönen P, Pakkala D. Reference architecture and classification of technologies, products and services for big data systems. Big Data Res 2015;2:166-86
74. Haider S, Ballester B, Smedley D, et al. BioMart Central Portal-unified access to biological data. Nucleic Acids Res 2009;37: W23-7
75. Barrett T, Wilhite SE, Ledoux P, et al. NCBI GEO: archive for functional genomics data sets-update. Nucleic Acids Res 2013;41:D991-5
76. Goode A, Gilbert B, Harkes J, et al. OpenSlide: a vendor-neutral software foundation for digital pathology. J Pathol Inform 2013;4:27
77. Pearson WR, Lipman DJ. Improved tools for biological sequence comparison. Proc Natl Acad Sci USA 1988;85:2444-8
78. Berman JJ, Edgerton ME, Friedman BA. The tissue microarray data exchange specification: a community-based, open source tool for sharing tissue microarray data. BMC Med Inform Decis Mak 2003;3:5
79. Unified Medical Language System (UMLS)-Home. https://www. nlm. nih. gov/research/umls/(20 November 2015, date last accessed)
80. Komatsoulis GA, Warzel DB, Hartel FW, et al. caCORE version 3: implementation of a model driven, service-oriented architecture for semantic interoperability. J Biomed Inform 2008;41: 106-23
81. Covitz PA, Hartel F, Schaefer C, et al. caCORE: a common infrastructure for cancer informatics. Bioinformatics 2003;19: 2404-12
82. Papatheodorou I, Crichton C, Morris L, et al. A metadata approach for clinical data management in translational genomics studies in breast cancer. BMC Med. Genomics 2009;2:66
83. Mohanty SK, Mistry AT, Amin W, et al. The development and deployment of Common Data Elements for tissue banks for translational research in cancer-an emerging standard based approach for the Mesothelioma Virtual Tissue Bank. BMC Cancer 2008;8:91
84. Patel AA, Kajdacsy-Balla A, Berman JJ, et al. The development of common data elements for a multi-institute prostate cancer tissue bank: the Cooperative Prostate Cancer Tissue Resource (CPCTR) experience. BMC Cancer 2005;5:108
85. Shiny. http://shiny. rstudio. com/(6 April 2016, date last accessed)
86. R. NET documentation-user version j R. NET-user version. http://jmp75. github. io/rdotnet/(6 April 2016, date last accessed)
87. matplotlib: python plotting-Matplotlib 1. 5. 1 documentation. http://matplotlib. org/(6 April 2016, date last accessed)
88. D3. js-Data-Driven Documents. https://d3js. org/(6 April 2016, date last accessed)
89. Fereidouni F, Datta-Mitra A, Demos S, et al. Microscopy with UV Surface Excitation (MUSE) for slide-free histology and pathology imaging. In: Progress in Biomedical Optics and Imaging-Proceedings of SPIE, San Francisco, CA, USA, 2015. p. 93180F. SPIE, Bellingham, WA, USA
90. Bird B, Miljkovic M, Romeo MJ, et al. Infrared micro-spectral imaging: distinction of tissue types in axillary lymph node histology. BMC Clin Pathol 2008;8:8
91. Taleb A, Diamond J, McGarvey JJ, et al. Raman Microscopy for the Chemometric Analysis of Tumor Cells. J Phys Chem B 2006;110:19625-31
92. Guze K, Pawluk HC, Short M, et al. Pilot study: Raman spectroscopy in differentiating premalignant and malignant oral lesions from normal mucosa and benign lesions in humans. Head Neck 2015;37:511-7
93. McNamee R. Regression modelling and other methods to control confounding. Occup Environ Med 2005;62:500-6
94. dos Santos Silva I. Dealing with confounding in the analysis. In: Cancer Epidemiology: Principles and Methods. Lyon, France: International Agency for Research on Cancer, 1999, 305-31
95. Queen's University Belfast j Postgraduate and Professional Development j MSc Bioinformatics and Computational Genomics. http://www. qub. ac. uk/schools/mdbs/pgd/PT/MScBioinformaticsandComputationalGenomics/(24 March 2016, date last accessed)
96. Dhir R, Patel AA, Winters S, et al. A multidisciplinary approach to honest broker services for tissue banks and clinical data: a pragmatic and practical model. Cancer 2008;113: 1705-15
97. Boyd AD, Hosner C, Hunscher D. A, et al. An 'Honest Broker' mechanism to maintain privacy for patient care and academic medical research. Int J Med Inform 2007;76:407-11
98. Pavlou MP, Diamandis EP, Blasutig IM. The long journey of cancer biomarkers from the bench to the clinic. Clin Chem 2013;59:147-57
99. ELIXIR Data for life. https://www. elixir-europe. org/(24 March 2016, date last accessed)
100. Research Infrastructure for Imaging Technologies in Biological and Biomedical Sciences j Euro-BioImaging. http://www. eurobioimaging. eu/(24 March 2016, date last accessed)